Northern Trust
VIVO

Northern Trust’s Meridian Bioscience Inc VIVO Stock Holding History

Northern Trust’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-551,260
Closed -$18.3M – 4690
2022
Q4 		$18.3M Buy
551,260
+12,209
+2% +$393K ﹤0.01% 1593
2022
Q3 		$17M Sell
539,051
-318
-0.1% -$10.3K ﹤0.01% 1600
2022
Q2 		$16.4M Buy
539,369
+1,038
+0.2% +$28.1K ﹤0.01% 1673
2022
Q1 		$14M Sell
538,331
-12,032
-2% -$286K ﹤0.01% 1927
2021
Q4 		$11.2M Sell
550,363
-13,772
-2% -$264K ﹤0.01% 2151
2021
Q3 		$10.9M Sell
564,135
-17,940
-3% -$358K ﹤0.01% 2209
2021
Q2 		$12.9M Buy
582,075
+47,619
+9% +$1.01M ﹤0.01% 2196
2021
Q1 		$14M Sell
534,456
-34,432
-6% -$819K ﹤0.01% 2069
2020
Q4 		$10.6M Sell
568,888
-24,742
-4% -$462K ﹤0.01% 2209
2020
Q3 		$10.1M Sell
593,630
-24,948
-4% -$485K ﹤0.01% 2102
2020
Q2 		$14.4M Buy
618,578
+67,684
+12% +$981K ﹤0.01% 1863
2020
Q1 		$4.63M Sell
550,894
-7,476
-1% -$62.9K ﹤0.01% 2344
2019
Q4 		$5.46M Buy
558,370
+578
+0.1% +$5.43K ﹤0.01% 2528
2019
Q3 		$5.29M Sell
557,792
-12,261
-2% -$129K ﹤0.01% 2516
2019
Q2 		$6.77M Sell
570,053
-27,733
-5% -$334K ﹤0.01% 2385
2019
Q1 		$10.5M Buy
597,786
+36,643
+7% +$610K ﹤0.01% 2111
2018
Q4 		$9.74M Sell
561,143
-17,011
-3% -$290K ﹤0.01% 2098
2018
Q3 		$8.62M Buy
578,154
+18,165
+3% +$282K ﹤0.01% 2343
2018
Q2 		$8.9M Buy
559,989
+10,119
+2% +$151K ﹤0.01% 2337
2018
Q1 		$7.81M Buy
549,870
+3,914
+0.7% +$57.9K ﹤0.01% 2329
2017
Q4 		$7.64M Sell
545,956
-6,958
-1% -$102K ﹤0.01% 2356
2017
Q3 		$7.91M Sell
552,914
-4,484
-0.8% -$64.1K ﹤0.01% 2347
2017
Q2 		$8.78M Buy
557,398
+8,886
+2% +$128K ﹤0.01% 2264
2017
Q1 		$7.57M Buy
548,512
+23,110
+4% +$323K ﹤0.01% 2312
2016
Q4 		$9.3M Buy
525,402
+10,018
+2% +$176K ﹤0.01% 2163
2016
Q3 		$9.94M Buy
515,384
+5,247
+1% +$103K ﹤0.01% 2085
2016
Q2 		$9.95M Buy
510,137
+6,754
+1% +$132K ﹤0.01% 2033
2016
Q1 		$10.4M Buy
503,383
+4,803
+1% +$94.6K ﹤0.01% 1953
2015
Q4 		$10.2M Buy
498,580
+19,909
+4% +$382K ﹤0.01% 1999
2015
Q3 		$8.19M Sell
478,671
-2,282
-0.5% -$41.7K ﹤0.01% 2130
2015
Q2 		$8.96M Sell
480,953
-1,165
-0.2% -$21.6K ﹤0.01% 2129
2015
Q1 		$9.2M Sell
482,118
-46,769
-9% -$865K ﹤0.01% 2124
2014
Q4 		$8.71M Sell
528,887
-75,364
-12% -$1.29M ﹤0.01% 2132
2014
Q3 		$10.7M Sell
604,251
-10,902
-2% -$214K ﹤0.01% 1993
2014
Q2 		$12.7M Sell
615,153
-94,069
-13% -$1.93M ﹤0.01% 1865
2014
Q1 		$15.5M Sell
709,222
-52,059
-7% -$1.19M ﹤0.01% 1786
2013
Q4 		$20.2M Sell
761,281
-2,970
-0.4% -$73K 0.01% 1513
2013
Q3 		$18.1M Sell
764,251
-9,228
-1% -$215K 0.01% 1539
2013
Q2 		$16.6M Buy
+773,479
New +$16.7M 0.01% 1521

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Northern Trust's VIVO Position: Q1 2023 in Review

Northern Trust sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 551,260 shares — an estimated $18.3M sold.

Northern Trust first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $20.2M in Q4 2013. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Northern Trust reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Northern Trust sold 551,260 Meridian Bioscience Inc shares in Q1 2023, an estimated $18.3M.
  • Northern Trust first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • Northern Trust's Meridian Bioscience Inc position peaked at $20.2M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.